Empower-cervical 1/GOG-3016/ENGOT-CX9:治疗复发/转移性宫颈癌的3期临床试验结果:cemiplimab vs研究者选择的化疗方案

K. Tewari, B. Monk, I. Vergote, A. Miller, A. de Melo, H. Kim, Y. Kim, A. Lisyanskaya, V. Samouélian, D. Lorusso, F. Damian, C-L. Chang, E. Gotovkin, Shin-ichiro Takahashi, D. Ramone, J. Pikiel, J. Li, M. Mathias, M. Fury, A. Oaknin
{"title":"Empower-cervical 1/GOG-3016/ENGOT-CX9:治疗复发/转移性宫颈癌的3期临床试验结果:cemiplimab vs研究者选择的化疗方案","authors":"K. Tewari, B. Monk, I. Vergote, A. Miller, A. de Melo, H. Kim, Y. Kim, A. Lisyanskaya, V. Samouélian, D. Lorusso, F. Damian, C-L. Chang, E. Gotovkin, Shin-ichiro Takahashi, D. Ramone, J. Pikiel, J. Li, M. Mathias, M. Fury, A. Oaknin","doi":"10.1136/ijgc-2021-igcs.1","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19692,"journal":{"name":"Oral abstracts","volume":"31 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"O001/#331 Empower-cervical 1/GOG-3016/ENGOT-CX9: results of phase 3 trial of cemiplimab vs investigator’s choice chemotherapy in recurrent/metastatic cervical carcinoma\",\"authors\":\"K. Tewari, B. Monk, I. Vergote, A. Miller, A. de Melo, H. Kim, Y. Kim, A. Lisyanskaya, V. Samouélian, D. Lorusso, F. Damian, C-L. Chang, E. Gotovkin, Shin-ichiro Takahashi, D. Ramone, J. Pikiel, J. Li, M. Mathias, M. Fury, A. Oaknin\",\"doi\":\"10.1136/ijgc-2021-igcs.1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19692,\"journal\":{\"name\":\"Oral abstracts\",\"volume\":\"31 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ijgc-2021-igcs.1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2021-igcs.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
O001/#331 Empower-cervical 1/GOG-3016/ENGOT-CX9: results of phase 3 trial of cemiplimab vs investigator’s choice chemotherapy in recurrent/metastatic cervical carcinoma
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信